David Steenblock, D.O., Uses Stem Cells and Other Therapies for Stroke Patients
Apr 20, 2017 11:01 am UTC| Business
SAN CLEMENTE, Calif., April 20, 2017 -- David Steenblock, an osteopathic physician based in San Clemente, CA, uses stem cells and other therapies to achieve significant and improved lifestyle outcomes for many stroke...
Key Appointment to Board of Directors at Cianna Medical, Inc.
Apr 20, 2017 11:01 am UTC| Business
ALISO VIEJO, Calif., April 20, 2017 -- Cianna Medical, Inc., the world leader in wire-free breast localization, announced that David M. Renzi has been elected to the Board of Directors. Cianna Medical manufactures and...
Key Appointment to Board of Directors at Cianna Medical, Inc.
Apr 20, 2017 11:01 am UTC| Business
ALISO VIEJO, Calif., April 20, 2017 -- Cianna Medical, Inc., the world leader in wire-free breast localization, announced that David M. Renzi has been elected to the Board of Directors. Cianna Medical manufactures and...
Apr 20, 2017 11:01 am UTC| Business
EDISON, NJ, April 20, 2017 -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, today announced new data...
Apr 20, 2017 11:01 am UTC| Business
EDISON, NJ, April 20, 2017 -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, today announced new data...
uniQure Announces It Will Not Seek Marketing Authorization Renewal for Glybera in Europe
Apr 20, 2017 11:01 am UTC| Business
-- Marketing Authorization for Glybera® to Expire on October 25, 2017 ---- Company Maintains Focus on Core Programs in Hemophilia B, Huntington’s Disease and Congestive Heart Failure --LEXINGTON, Mass. and AMSTERDAM, the...
uniQure Announces It Will Not Seek Marketing Authorization Renewal for Glybera in Europe
Apr 20, 2017 11:01 am UTC| Business
-- Marketing Authorization for Glybera® to Expire on October 25, 2017 ---- Company Maintains Focus on Core Programs in Hemophilia B, Huntington’s Disease and Congestive Heart Failure --LEXINGTON, Mass. and AMSTERDAM, the...